Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Celyad Sa ADR
(NQ:
CYAD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Celyad Sa ADR
< Previous
1
2
3
4
Next >
Earnings Scheduled For March 24, 2022
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 09, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock rose 222.4% to $4.9 during Wednesday's pre-market session. The company's market cap stands at $21.9 million. TC...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 07, 2022
Gainers
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 04, 2022
Gainers Atreca (NASDAQ:BCEL) stock moved upwards by 43.1% to $2.39 during Friday's regular session. As of 12:30 EST, Atreca's stock is trading at a volume of 19.1...
Via
Benzinga
FDA Slaps Clinical Hold On Celyad's Phase 1 Colorectal Cancer Trial
March 02, 2022
The FDA has issued a clinical hold on Celyad Oncology SA's (NASDAQ: CYAD) CYAD-101-002 (KEYNOTE-B79) Phase 1b trial due to insufficient information to...
Via
Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
March 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 01, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 172.1% to $0.92 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 157.8...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 28, 2022
Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 01, 2022
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a...
Via
Benzinga
Celyad Stops Early-Stage Colorectal Cancer Trial Amid Reported Fatalities
February 28, 2022
Celyad Oncology SA (NASDAQ: CYAD) has decided to voluntarily pause the CYAD-101-002 (KEYNOTE-B79) Phase 1b trial, a part of a collaboration with Merck & Co...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 07, 2021
Gainers PLx Pharma (NASDAQ:PLXP) stock in...
Via
Benzinga
58 Biggest Movers From Friday
December 06, 2021
Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
Gainers Lixte Biotech Holdings (NASDAQ:LIXT
Via
Benzinga
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
December 03, 2021
Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
December 03, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2...
Via
Benzinga
Stocks Eye Daily, Weekly Drops as Omicron Variant Spreads
December 03, 2021
This morning's rally was short-lived. The major indexes are headed toward both daily and weekly losses at midday.
Via
Talk Markets
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
December 03, 2021
Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
SWBI Stock: Why Smith & Wesson Shares Are Getting Gunned Down Today
December 03, 2021
Smith & Wesson (SWBI) stock is feeling the heat on Friday following the release of its fiscal second-quarter 2022 earnings report.
Via
InvestorPlace
Topics
Firearms
Exposures
Firearms
Hot Biotech Stocks: Why Celyad Oncology (CYAD) Is Soaring Higher Today
December 03, 2021
Celyad Oncology (CYAD) stock is heading higher on Friday following the announcement of a $32.5 million private placement.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
December 03, 2021
Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Celyad Oncology Shares Gain After Fortress Injects $32M Via Equity
December 03, 2021
Celyad Oncology SA (NASDAQ: CYAD) has announced a private placement worth $32.5 million (about €28.7 million) with Fortress Investment Group. The offering...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million. Biolase (...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 03, 2021
Good morning, investor! We're at the end of the week and it starts off with the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.